According to Thelansis the estimated total patient pool of chemotherapy induced peripheral neuropathy (CIPN) in 8 MM countries are reported to be 3.35 MN in 2020, 3.47 MN in 2025 and 3.57 MN by 2030.

The Friedreich’s ataxia (FA) market insight report provides a comprehensive view of disease events, severity, identified and emerging biomarkers, treatment guidelines, epidemiology, market forecast, etc.

Charcot-Marie-Tooth disease (CMT) is one of a group of disorders that cause damage to the peripheral nerves.

Thelansis “Acromegaly - Market outlook, Epidemiology, Market Forecast and Competitive Land- scape - 2020 To 2030 ”.

Thelansis Crohn’s disease (CD) is a chronic disorder characterized by exacerbations and periods of remission that cause inflammation of the gastrointestinal (GI) tract.